1 T-cell help (CD4 help) plays a pivotal role in CD8 1 T-cell responses against viral infections. However, the role in primary CD8
INTRODUCTION

CD8
1 T cells are one of the key effectors in adaptive immunity and they play a critical role in protection from various pathogens. Viruses entering the body via various routes will face different microenvironments where different cells reside and interact. T-cell responses to a typical acute viral infection can be characterized into three major phases: effector T-cell expansion and differentiation, contraction, and memory T-cell formation. These phases are precisely driven and controlled by T-cell receptor engagement, costimulation and inflammatory cytokines as well as CD4
1 T-cell help (CD4 help). 1 T-cell receptors of naive CD8 1 T cells recognize a specific epitope presented by MHC class I (MHC I) on antigen-presenting cells (APCs), constituting 'signal 1', which initiates a primary response and starts clonal expansion and differentiation. 2 Once activated, the expansion of CD8 1 T cells is preprogrammed and does not require further contact with antigen (Ag). 3, 4 Ag-independent expansion is supported by IL-2 and further augmented by IL-7 or IL-15. 3 Costimulation provided by APCs, acting as 'signal 2', is essential to induce full activation of T cells and prevents them from becoming refractory to Ag stimulation. 5 The most important costimulatory pathways include CD28/CD80-CD86, 6 CD40L/CD40, 7 CD27/CD70, 8 4-1BB/4-1BBL 9 and OX-40/OX40L. 10 Furthermore, inflammatory cytokines, such as IL-12 and type I IFNs, provide 'signal 3' at distinct stages of the response for optimal generation of effector and memory populations. 11 In addition to these three signals, CD4 help plays a pivotal role in CD8
1 T-cell responses. 12 A number of studies have confirmed that CD4 help is required for development of CD8 1 T-cell memory and secondary expansion of CD8 1 T cells. [13] [14] [15] [16] However, the role of CD4 help in the primary CD8 1 T-cell response remains controversial, since differing and even contradictory results are frequently observed. CD4 help is necessary in priming CD8
1 T cells with non-infectious agents (such as minor histocompatibility Ags, tumor Ags, Agloaded splenocytes, grafts, alloantigens and soluble protein Ags), but is variably required for CD8
1 T-cell responses to infectious agents. 17 CD4 help is required for the primary CD8
1 T-cell response to herpes simplex virus, 18 but not to vesicular stomatitis virus infection. 19 It is required for sustaining cytotoxic T lymphocyte (CTL) responses during chronic infection with lymphocytic choriomeningitis virus variants, but not for resolving acute lymphocytic choriomeningitis virus infection. 20 These data indicate that the identity of the pathogen is an important variable. Furthermore, divergent results regarding the role for CD4 help have been reported with the same pathogen. 17 In vaccinia virus (VACV) infection, primary CD8
1 T-cell responses have been shown to be dependent on CD4
1 T cells in some reports, [21] [22] [23] while other studies report CD4 help independence. 14, 24 Different experimental conditions were used in these studies, including the VACV strain, inoculum dose and route of infection as well as the mouse model.
VACV, a dsDNA virus, belongs to the family Poxviridae and the genus Orthopoxvirus and shares high homology with other orthopoxviruses, such as variola virus (the smallpox in humans), ectromelia virus (mousepox) and monkeypox. 25 The natural reservoir of VACV is not known, but it can replicate in mice. VACV vaccination was one of the most important medical practices in human history, resulting in the eradication of smallpox. Attenuated VACV has been used as a vaccine vector against infectious agents and cancers, and as a gene delivery system to study biological functions of foreign genes. 26 VACV-infected mouse models have been used extensively in the study of acute virus infection. Depending on experimental settings, VACV is administered by various routes, e.g., intranasal, 24 intraperitoneal, 14, [21] [22] [23] 27 intradermal, 28 intracranial 29 and intravenous. 30 Despite numerous previous studies, there lacks a side-byside comparison of the CD4 dependency of the CD8 1 T-cell response when either the viral dose or route of VACV infection is varied. Here we used MHC class II knockout (MHC II 2/2 ) mice to determine the CD4 help dependence of primary CD8 1 T-cell response to VACV Western Reserve strain infection by comparing the response in intranasal and intraperitoneal infection. Our data demonstrate that the requirement for CD4 help in primary CD8
1 T-cell response against VACV infection varies depending on the route of infection and viral dose, and intranasal infection induces more potent effector CD8 1 T cells than intraperitoneal infection.
MATERIALS AND METHODS
Mice and generation of mixed bone marrow chimeric mice C57BL/6 (B6) and congenic B6-Ly5.2/Cr mice were purchased from the National Cancer Institute (Frederick, MD, USA Virus, viral infection and plaque assay Vaccinia virus Western Reserve strain (VACV-WR) was obtained from Dr William R Green (Geisel School of Medicine at Dartmouth, Lebanon, NH, USA), and was propagated and titered in the 143B cell line. Mice were infected with 10 3 PFU of VACV in 30 ml of PBS for intranasal inoculation (i.n.) or in 300 ml of PBS for intraperitoneal inoculation (i.p.) unless otherwise noted. For i.n. infection, mice were anesthetized with isoflurane. Virus titers in the lungs and ovaries were measured by plaque-forming assay as previously described. 32 Plaques were counted microscopically.
Tissue and cell preparations
To obtain single cell suspensions, spleens and livers were homogenized by passing through cell strainers, and red blood cells were lysed using Gey's solution. Lungs and livers were digested with collagenase (2.33 mg/ml) (Sigma-Aldrich, Milwaukee, WI, USA) and DNase (0.2 mg/ml) (Roche Diagnostics, Indianapolis, IN, USA) for 30 min.
Antibodies (Abs) and flow cytometry Abs for flow cytometric analysis were purchased from eBioscience or BioLegend (San Diego, CA, USA) unless otherwise noted: CD8a PerCP-eFluor 710 (53-6.7), CD127 FITC (SB/199), KLRG1 PE (2F1 KLRG1), IFN-c APC (XMG1.2), TNF-a FITC (MP6-XT22), granzyme B (GzmB) PE (GB12; Invitrogen, Carlsbad, CA, USA). Samples were analyzed using Accuri flow cytometers or MacsQuant flow cytometers in the Dartlab core facility at Geisel School of Medicine at Dartmouth. Data were analyzed using FlowJo software (Tree Star, Ashland, OR, USA) or Accuri software (BD Biosciences).
MHC/peptide tetramer
The VACV-specific epitope B8R [20] [21] [22] [23] [24] [25] [26] [27] , TSYKFESV, was made as a synthetic peptide based on the original MVA (modified vaccinia virus Ankara) sequence. 33 Peptide MHC I tetramers consisting of B8R [20] [21] [22] [23] [24] [25] [26] [27] /K b conjugated to allophycocyanin were obtained from the NIH Tetramer Core Facility (Emory University, Atlanta, GA, USA). Cells were stained with the tetramer together with Fc block (2.4G2) for 1 h at room temperature in the dark in PBS with 2% bovine growth serum, followed by surface staining at 4 uC for 20 min in 96-well Ubottom plates and were analyzed by flow cytometry.
Staining of surface markers and intracellular cytokines/ effector molecules Surface markers were stained with Abs in PBS with 2% bovine growth serum for 20 min at 4 uC. For intracellular cytokine/ effector molecule detection, splenocytes from infected mice were restimulated ex vivo with 1 mg/ml B8R peptide for 5 h at 37 uC in complete medium with 10 U/ml rIL-2 and 10 mg/ml brefeldin A (Sigma-Aldrich). Subsequently, cells were stained with Abs against surface markers, followed by fixation with 1% formaldehyde for 20 min at 4 uC and then stained with Abs against IFN-c, TNF-a or GzmB in 0.5% saponin solution for 30 min at 4 uC.
Depletion of CD4
1 T cells Mice were administered i.p. 500 mg of anti-CD4 Ab (GK1.5), at days 21 and 0 of infection, followed by 250 mg twice weekly thereafter until the mice were sacrificed. Control mice were either untreated or given rat IgG (Jackson ImmunoResearch Laboratories, West Groove, PA, USA). No differences in T-cell responses were observed in the two groups of control mice (data not shown).
Blockade of CD40L
CD40L blocking Ab MR-1 (500 mg) (BioXcell, West Lebanon, NH, USA) was administrated i.p., starting at days 21 and 0 of infection, followed by every 2 days throughout the duration of the experiments. Control mice were either untreated or given rat IgG.
Measurement of cell proliferation
To measure turnover of B8R-specific CD8 1 T cells in vivo, cell proliferation was measured by 5-bromo-29-deoxyuridine (BrdU) staining. Mice were injected 1 mg BrdU (i.p.) twice at 12 h apart, starting at day 8 post infection (pi). Splenocytes were prepared 18 h later, and cells were stained with anti-CD8a Ab and B8R tetramer, and then stained with the anti-BrdU Ab according to the protocol provided (BD Pharmingen G, San Jose, CA, USA).
Apoptosis assay by Annexin V staining Splenocytes were prepared from infected mice at day 10 pi. Cells were stained with B8R tetramer, anti-CD8a Ab and Annexin V using an Apoptosis Detection Kit (BD Biosciences). The Annexin V staining was performed in conjunction with 7-aminoactinomycin D (7-AAD), since viable cells with intact membranes can exclude 7-AAD.
Cytotoxicity assays in vivo and ex vivo For in vivo cytotoxicity assay, splenocytes were prepared from B6 mice and were incubated with 1 mg/ml B8R peptide in complete medium at 37 uC for 1 h. The B8R-pulsed andunpulsed cells were labeled with 2.5 mM and 0.25 mM CFSE, respectively, in HBSS at room temperature for 10 min. The B8R-pulsed (CFSE hi ) and -unpulsed (CFSE lo ) cells were mixed at a 1 : 1 ratio and used as target cells. 2310 7 target cells were injected i.v. into i.n. infected wild-type (WT) or MHC II 2/2 mice at day 9 pi, or naive WT mice. Six hours later, mice were killed and splenocytes were stained with 10 mM 7-AAD at room temperature for 15 min. CFSE-positive and 7AAD-negative cells were analyzed by flow cytometry. Specific lysis was evaluated with percent specific killing, calculated according to the formulas: % specific lysis5(12[ratio of infected recipients/ ratio of naive recipients])3100%, where ratio5number of CFSE hi /number of CFSE lo . For ex vivo cytotoxicity assay, effector CD8
1 T cells were prepared from splenocytes of i.p. infected WT or MHC II 2/2 mice at day 10 pi by staining with anti-CD8a Ab and B8R tetramer. Target cells were prepared as described in in vivo cytotoxicity assay. Effector B8R-specific CD8
1 T cells were cultured with target cells at a ratio of 5 : 1 (10 5 : 2310 4 , normalized to the same total number of B8R-specific CD8
1 T cells) in complete media in 96 well plates at 37 uC for 6 h. Cells were then stained with 10 mM 7-AAD at room temperature for 15 min and CFSE-positive and 7AAD-negative cells were analyzed by flow cytometry. Specific lysis was calculated based on the formulas: % specific lysis5[12(ratio of WT or MHC II 2/2
B8R
1 CD8 1 group/ratio of target alone group)]3100%, where ratio5number of CFSE hi /number of CFSE lo .
Statistical analysis
Student's t-tests (two-tailed, unpaired) were performed using GraphPad Prism 5 (GraphPad, La Jolla, CA, USA). Values of P,0.05 were considered statistically significant.
RESULTS
CD4 help deficiency impairs primary VACV-specific CD8
1 T-cell responses in intraperitoneally infected mice but not in intranasally infected mice Clonal expansion of Ag-specific CD8 1 T cells is essential for adaptive immunity to viral infection. Upon infection, Ag-specific CD8
1 T cells can undergo 10 4 -to 10
5
-fold expansion in a week. 34 It is estimated that there are approximately 1070 naive CD8 1 T cells/spleen specific for B8R [20] [21] [22] [23] [24] [25] [26] [27] , a dominant epitope of VACV in mice. 35 We first studied the kinetics of the VACVspecific CD8
1 T-cell response by tetramer staining of B8R-specific CD8
1 T cells. WT B6 mice and MHC II 2/2 mice were infected i.n. or i.p. with 10 3 PFU of VACV, a dose less than the lethal dose of 10 5 PFU via i.n. infection. 32 WT and MHC II 2/2 mice infected i.n. mounted a robust primary CD8 1 T-cell response, and expansion of B8R-specific CD8 1 T cells reached a peak at d10 pi in the spleen (Figure 1a and b) and the lung (Supplementary Figure 1) . Over time, B8R-specific CD8
1 Tcell populations contracted, and the population in MHC II 2/2 mice had a faster contraction than that had in the WT cohort by d21 pi. In contrast, the i.p. infected MHC II 2/2 mice had an attenuated primary CD8
1 T-cell response, and the number of B8R-specific CD8 1 T cells was significantly reduced, compared with infected WT mice in the spleen (Figure 1a and b) and the lung (Supplementary Figure 1) . Similar results were also observed in mice that were depleted of CD4 1 T cells using anti-CD4 Ab (GK1.5) (data not shown). 1 T cells at d9 pi. (d) Viral titers in lungs and ovaries, determined by plaque-forming assays. Each point on the graph represents a single mouse, and horizontal bars indicate the means. Data are representative of two to three independent experiments with three to eight mice per group. **P,0.01; ***P,0.001. Ab, antibody; i.n., intranasally; i.p., intraperitoneally; ns, not significant; pi, post infection; VACV-WR, vaccinia virus Western Reserve; WT, wild-type. 38 In this study, the frequency of cells expressing KLRG1 was reduced and CD127 expression was at a higher level on B8R-specific CD8
1 T cells in MHC II 2/2 mice compared to WT mice, and there were no significant differences between the i.p. and i.n. infections (Figure 1c ). These data indicate that SLECs are diminished in the absence of CD4 help.
To study the effect of the diminished primary CD8 1 T-cell response on viral control, we detected viral load by plaqueforming assay. Lungs and ovaries are the major organs for VACV replication in the i.n. and i.p. infection, respectively. 27, 39 In this experiment, infection led to high viral titers in both WT and MHC II 2/2 mice at d5 pi, regardless of infection route. The viral titers declined by d10 pi, but higher viral burdens remained in the organs of MHC II 2/2 mice in both i.n. and i.p. infected groups (Figure 1d ). This indicates that the absence of CD4 help impairs viral control, but does not strictly correlate with the size of the B8R-specific CD8
1 T-cell population. The high affinity Ab response is also impaired in MHC II 2/2 mice, 27 and this likely contributes to the reduction in virus control observed in these mice.
Viral dose determines the CD4 help dependence of VACVspecific CD8
1 T-cell expansion in intranasally infected mice We wished to explore factors contributing to the difference in the requirement for CD4 help in clonal expansion between i.n. infection and i.p. infection. First, we analyzed the effect of viral load by administering different doses of virus. In previous experiments (Figure 1 ), our standard inoculating dose of virus was 10 3 PFU/mouse in both i.n. and i.p. infections. For i.p. infection, both 10 4 PFU and 2310 6 PFU doses manifested the same CD4 help dependence as was seen with the standard 10 3 PFU dose (Figure 2a ). The data indicate that an increased initial viral load does not preclude the requirement of CD4 help for primary CD8
1 T-cell responses in i.p. infection. Unexpectedly, when reducing inoculated dose (10 2 PFU of VACV) in i.n. infected MHC II 2/2 mice, generation of B8R-specific CD8
1 T cells did need CD4 help. The population of B8R-specific CD8 1 T cells in MHC II 2/2 mice was smaller compared to WT mice (Figure 2b ). These data suggest that while the requirement for CD4 help in the i.p. infection cannot be compensated by a high virus load, CD4 help in i.n. infected mice is required when a low virus dose is administered. Accordingly, inoculated viral dose is another factor determining dependence on CD4 help for primary CD8
1 T-cell responses.
Enhanced effector capacity in VACV-specific CD8 1 
T cells following intranasal infection, compared with intraperitoneal infection
To test the influence of infection route and CD4 help on effector molecule production, we measured production of cytokines IFN-c and TNF-a as well as effector molecule GzmB by activated CD8 1 T cells. IFN-c 1 CD8 1 T cells from i.n. infected mice produced more IFN-c on a per cell basis, as determined by mean fluorescence intensity (MFI), compared with i.p. infected mice, regardless of CD4 help (Figure 3a) . The frequency of TNF-a 1 cells (Figure 3b, top) , and production of TNF-a per cell (Figure 3b , bottom) were significantly higher in the IFN-c 1 CD8 1 T cells from i.n. infected mice than those from i.p. infected mice. Interestingly, regardless of infection route, mice lacking CD4 help contained a higher frequency of cells producing both IFN-c and TNF-a than WT mice (Figure 3b ). Production of GzmB was higher on a per cell basis in the IFN-c 1 CD8 1 T cells from i.n. infected mice than those from i.p. infected mice (Figure 3c ). These results indicate that i.n. infection can induce enhanced production of IFN-c, TNFa and GzmB from IFN-c 1 CD8 1 T cells, compared to i.p. infection. In addition, the absence of CD4 help did not reduce the effector cytokine/molecule production by B8R-specific CD8 1 T cells.
CD4 help-deficiency does not affect cytotoxic activity of VACV-specific CD8 1 T cells We performed an in vivo cytotoxicity assay to assess effect of CD4 help on the activity of VACV-specific CD8 1 T cells in i.n infected WT and MHC II 2/2 mice. As these mice had the same frequency of B8R-specific CD8 1 T cells (Figure 1b) , a direct comparison between the two groups could be made using this assay. B8R-pulsed (CFSE hi ) and -unpulsed (CFSE lo ) splenocytes from B6 mice were mixed as target cells, and 2310 7 of the target cells were injected to WT and MHC II 2/2 mice at d10 pi. Six hours later, spleens were harvested and target cells were detected by flow cytometry. B8R-pulsed target cells were completely cleared from VACV-infected mice, and there was no difference between WT and MHC II 2/2 mice (Figure 4a ). This indicated highly effective cytotoxic function in both WT and CD4 help-deficient groups.
Since B8R-specific CD8 1 T cells in i.p. infected MHC II 2/2 mice were present at a much lower level than that in i.p. infected WT mice (Figure 1b) , the in vivo cytotoxicity assay could not be used to compare these groups directly. Thus, we performed an ex vivo cytotoxicity assay to assess effect of CD4 help on CTL activity in i.p. infected WT and MHC II 2/2 mice. Target cells were prepared in the same way as those in the in vivo cytotoxicity assay. Effector B8R-specific CD8
1 T cells were prepared from the splenocytes of i.p. infected WT and MHC II 2/2 mice at d10 pi. Effector cells were cocultured with target cells at a ratio of 5 : 1 for 6 h. The specific lysis was approximately 20% and there was no difference in CTL activity between the two groups ( Figure 4b ). This result is in agreement with previous work with 51 Cr release assays in which cytotoxicity toward VACV-infected target cells is not diminished in i.p. infected CD4
1 T cell-depleted mice. 27 These data suggest that cytotoxic activity of VACV-specific CD8 1 T cells is not affected by the absence of CD4 help.
Differential requirement for IL-2 signaling through CD25 in i.n. versus i.p. infection CD4 1 T cell-derived IL-2 is essential for help-dependent primary CD8
1 T-cell responses, 40 and CD25 (IL-2 receptor a) is necessary to form the high-affinity IL-2 receptor. We investigated whether there were the same requirements for the highaffinity IL-2 receptor in CD8
1 T-cell responses in mice infected by either the i.n. or i.p. route. Mixed BM chimeric mice were used, that contained both WT CD25 1/1 (CD45.1 1 ) and CD25 2/2 (CD45.2 1 ) cells. CD25 2/2 mice cannot be used directly due to severe autoimmune disease in these mice because they lack regulatory T cells. 41 Spleens, lungs, peripheral blood lymphocytes (PBLs), BM and livers were collected from the chimeric mice at d10 pi. Cells were stained with B8R tetramer and anti-CD8a Ab. The expansion of CD25 2/2 B8R-specific CD8 1 T cells was significantly diminished compared to WT cells in i.p. infected chimeric mice, which is consistent with our previous studies. 22 In contrast, i.n. infected chimeric mice mounted strong CD8 1 T-cell responses from both the WT and CD25
2/2 compartments and no statistical differences could be detected in the spleens, lungs, BM or livers (Figure 5b) . A small but statistically significant difference was detected in the PBL; however, this difference was smaller than that observed in the PBL of i.p. infected chimeric mice. The data demonstrate that CD25-deficiency significantly 
CD8
1 T cells. Data are representative of two independent experiments with three to four mice per group. *P,0.05; **P,0.01; ***P,0.001. Ab, antibody; GzmB, granzyme B; MFI, mean fluorescence intensity; ns, not significant; pi, post infection; VACV, vaccinia virus.
CD4 dependence of primary CD8
1 T-cell response Z Hu et al diminishes the expansion of the VACV-specific CD8
1 T-cell pool in mice infected i.p. but not i.n., suggesting that there are compensatory mechanisms in play during lung infection.
Role of CD40-CD40L pathway in the generation of VACVspecific CD8
1 T-cell population in i.n. infection It has been reported that signaling via the CD40-CD40L pathway can replace CD4 help in priming the CTL response. 42, 43 In this experiment, we measured generation of B8R-specfic CD8 1 T cells in mice that were administered CD40L blocking Ab (MR-1) and infected i.n. with 10 2 PFU of VACV. This viral dose was used as it induces a CD4 help-dependent response after i.n. infection (Figure 2b) . Blockade of CD40L resulted in populations of B8R-specific CD8
1 T cells that were significantly smaller than in WT mice, and similar to MHC II 2/2 mice (Figure 6a ). The data indicate that CD40-CD40L signaling is required for expansion of B8R-specific CD8 1 T cells in i.n. infection with as mall viral dose. In contrast, for i.n. infection with 10 3 PFU of VACV, blockade of CD40-CD40L signaling did not significantly affect the expansion of the B8R-specific CD8
1 T-cell population in both WT and MHC II 2/2 mice ( Figure 6b ). This is consistent with the CD4 help-independent status of the response after i.n. infection with 10 3 PFU of VACV (Figure 1a and b) . Thus, whether CD40-CD40L signaling is required for expansion of B8R-specific CD8
1 T cells depends upon viral dose after i.n. infection.
CD4 help deficiency results in increased apoptosis of VACVspecific CD8
1 T cells We measured the proliferation of B8R-specific CD8
1 T cells in vivo by BrdU incorporation. Mice were administered BrdU at d8 pi, and 18 h later, splenocytes were prepared and stained with anti-CD8a Ab and B8R tetramer, and then with antiBrdU Ab. B8R-specific CD8 1 T cells from WT and MHC II 2/2 mice had similar rates of BrdU incorporation, regardless of infection route, indicating that Ag-specific CD8 1 T cells were able to proliferate equivalently in CD4 help-deficient mice and WT mice (Figure 7a) .
Next, we determined the proportion of B8R-specific CD8 1 T cells undergoing apoptosis in the absence of CD4 help, using Annexin V staining in conjunction with 7-AAD, since viable cells with intact membranes can exclude 7-AAD. Splenocytes were prepared from WT and MHC II 2/2 mice at d9 pi. The proportions of Annexin V 1 cells in B8R-specific CD8 1 7-AAD 2 T cells were higher in cells from MHC II 2/2 mice than those from WT mice in both i.n. and i.p. infection (Figure 7b ). This indicates that VACV-specific CD8 1 T cells undergo more apoptosis in the absence of CD4 help.
We also determined the proportion of cells undergoing apoptosis in the absence of CD40L signaling in i.n. infected mice with different viral doses. Blockade of CD40L resulted in more apoptosis in mice infected with 10 3 PFU (Figure 7c , left) and 10 2 PFU (Figure 7c , right) compared to the WT cohort. These data suggest that CD40-CD40L pathway is responsible for preventing apoptosis of VACV-specific CD8 1 T cells. 1 T cells) were prepared from splenocytes of i.p. infected mice (10 3 PFU) at d10 pi. Effector cells were cultured with target cells at 5 : 1 ratio (normalized to same total number of B8R-specific CD8
DISCUSSION
1
T cells) for 6 h, and CFSE-labeled target cells were analyzed. Percent specific lysis is shown. Data are representative of two independent experiments with three to four mice per group. i.n., intranasally; i.p., intraperitoneally; ns, not significant; pi, post infection; VACV, vaccinia virus.
CD4
1 effector T cells, respectively. 44 Intravenous and intrarectal infections with simian immunodeficiency virus result in difference in time of virus appearance in the blood and size of the virus-specific immune response, and the natural mucosal barrier may delay viral spreading. 45 By examining intradermal, subcutaneous, i.p. or i.v. infection, studies have shown that the immunodominance hierarchy is also affected by the route of infection. 46 Additionally, the role of CD4 help in the CD8 1 Tcell responses does not follow a simple on-off rule. In herpes simplex virus 1 infection, the primary CD8 1 T-cell response is strictly CD4 help-dependent with subcutaneous (footpad) infection, 47, 48 but is largely independent with ocular infection. 49 In this study with 1310 3 PFU VACV-WR infection, B8R-specific CD8
1 T cells displayed a poor expansion (Figure 1a and b) in i.p. infected CD4 help deficient mice. In contrast, after i.n. infection, B8R-specific CD8
1 T cells expanded equivalently in either the presence or absence of CD4 help. These data indicate that the route of infection can markedly affect Ag-specific CD8 1 T-cell responses in the absence of CD4 help.
We studied the effect of Ag dose by inoculating various doses of VACV. An increased viral load could not restore expansion of B8R-specific CD8 1 T cells in i.p. infection, even when the dose was increased to 2000-fold more than the standard dose used in this study (Figure 2a ). This suggested that for VACV-WR infection, dependency on CD4 help could not be overcome by providing more Ag stimulation. Consistent with our data, another group also demonstrated that primary CD8
1 T-cell expansion is dependent on CD4 help when mice were infected i.p with 5310 6 PFU of VACV (VV-G2). 23 While another report found CD8
1 T-cell expansion was not dependent on CD4 help after i.p. infection with 10 7 PFU of VACV (rVV33), 14 this study 1 T cells were detected in various organ/tissues, including the spleens, lungs, BM, livers and PBLs. *P,0.05; **P,0.01; ***P,0.001. BM, bone marrow; i.n., intranasally; i.p., intraperitoneally; ns, not significant; PBL, peripheral blood lymphocyte; pi, post infection; VACV, vaccinia virus; WT, wild-type.
CD4 dependence of primary CD8
1 T-cell response Z Hu et al
used CD4
2/2 mice, which we now know contain an aberrant population of 'helper' CD8 1 T cells. 50 Our studies show that reduction in the viral load, from 10 3 to 10 2 PFU, did result in dependence on CD4 help following i.n. infection (Figure 2b ). These data indicate that in addition to route of infection, viral dose is also an important factor determining the degree to which primary CD8 1 T-cell responses require CD4 help. We analyzed the profiles of antiviral effector molecules or cytokines. B8R-specific CD8 1 T cells produced more IFN-c, TNF-a and GzmB in i.n. infected mice than in i.p. infected mice, regardless of CD4 help (Figure 3 ). Although the underlying mechanism is not clear, higher expression of effector molecules by B8R-specific CD8 1 T cells in i.n. infection may be a result of the mucosal microenvironment in the lung. It would therefore be interesting to determine if the same is true for other mucosal routes of infection. Additionally, we analyzed cytotoxicity of CD8 1 T cells in the absence of CD4 help. The VACV-specific CD8
1 T cells showed similar cytotoxic activity in WT and MHC II 2/2 mice (Figure 4 ). Therefore cytotoxic function is not impaired in the absence of CD4 help, regardless of the route of infection.
T helper cell-derived IL-2 is a central component of help for CD8 1 T-cell responses. 40 Our lab has previously reported that CD4
1 T cells upregulate CD25 expression on Ag-specific CD8 1 T cells, thereby promoting the expansion of the virusspecific CD8
1 T-cell population, specifically SLECs. 22 Other studies have shown that IL-2 signaling promotes expression of the transcription factor Blimp-1, which is necessary for differentiation of SLECs. 51 In this study, we confirmed that signaling through CD25 was essential for driving expansion of the population after i.p. infection, but not after i.n. infection ( Figure 5 ). The data suggest that deficiency of IL-2/CD25 signaling may be partially responsible for the reduced primary B8R-specific CD8
1 T-cell response in the absence of CD4 help following i.p. infection. However, i.n. infected mice did not show dependence on the IL-2/CD25 pathway, suggesting that some pathways or signaling in lung infection can replace or compensate for CD4 help.
Dendritic cells (DCs) are potent professional APCs, bridging the innate and adaptive immune systems to induce primary immune responses. 52, 53 A CD4 help signal is transmitted from DCs to CD8 1 T cells partly via CD40-CD40L interactions between DCs and CD4 1 T cells. 42 Immunization with noninfectious agents requires the CD4 help, 17 and CD40-CD40L signaling can replace CD4 help in priming of CTL responses to Ag-loaded splenocytes and alloantigen. 42, 43 In addition, upregulating CD40L on DCs can promote optimal priming of CD8 1 T cells against influenza in the absence of CD4 help. 54 Work from our lab has shown that expansion of the VACVspecific CD8 1 T-cell population in CD40 2/2 mice is equivalent to WT mice after i.p. infection. 22 However, Wiesel et al.
23
found that expansion of VACV-specific CD8 1 T cells is impaired in the absence of CD40-CD40L in i.p. infection. Differences in the infectious dose, the viral strain and mouse model might partly explain the discrepancy. In this study, expansion of virus-specific CD8 1 T-cell population was dependent on CD4 help (Figure 2b ) and the CD40-CD40L pathway (Figure 6a ) in i.n. infected mice with 10 2 PFU of VACV. This suggests that CD4 help through CD40-CD40L signaling is required for optimal primary CD8 1 T-cell responses when mice are infected i.n. at a small viral dose. In contrast, after i.n. infection with 10 3 PFU of VACV, the expansion was independent of CD4 help (Figure 1a and b) and the CD40-CD40L pathway (Figure 6b) . Recognition of microbial products by Toll-like receptors directly activate APCs and thus, bypass the need for CD4 help. 55 We are currently investigating whether higher viral doses result in better DC maturation, which may reduce the requirement for CD4 help.
To explore the mechanism by which the absence of CD4 help resulted in a smaller population of B8R-specific CD8
1 T cells, we measured proliferation and apoptosis of VACV-specific CD8 1 T cells. The B8R-specific CD8 1 T cells proliferated normally in the absence of CD4 help regardless of the route of infection (Figure 7a ). However, CD4 help deficiency resulted in increased apoptosis of the B8R-specific CD8 1 T cells in mice infected either i.n. or i.p. (Figure 7b ). This agrees with previous reports in which an i.p. infected mouse model was used. 21, 23 Moreover, CD40L signaling-deficiency also resulted in increased apoptosis of the B8R-specific CD8 1 T cells in i.n. infected mice regardless of viral dose (Figure 7c ). Increased apoptosis may contribute to the reduced clonal expansion observed in i.p. infected mice lacking CD4 help. However, a similar increase in apoptosis was observed following i.n. infection, but this was insufficient to reduce the clonal expansion. Currently, we do not know the mechanism underlying this discrepancy. Possibly B8R-specific cell death rates are not increased in organs other than the spleen, and there may be differential recruitment of these cells to the spleen in the presence or absence of CD4 1 T cells. Alternatively, there may be another, as yet undefined, mechanism that may compensate for reduced CD8
1 T-cell viability during respiratory infection in the absence of CD4 help.
As the front line exposed to the air, the lung is equipped with an elaborate network of DCs to sense entering pathogens. 56 Studies have demonstrated that mucosal vaccination is more effective than systemic vaccination in establishing protective mucosal immune responses. 57 This is because an optimum mucosal vaccine strategy can activate local innate immune responses for generating neutralizing sIgA Abs, polyfunctional CD8
1 CTLs and CD4 1 T-cell effector memory responses. 57 Our findings demonstrate that there is remarkable variability in the dependence of the CD8 1 T-cell response on CD4 help. The identical pathogen can have differing requirements for CD4 help owing to a different route of infection or viral dose. In addition, infection in the lung microenvironment may favor superior effector activity in virus-specific CD8 1 T cells. Natural infections with orthopox viruses occur through the respiratory tract; thus, the i.n. infection model may provide some important insights into the host response to VACV infection. This information is also very relevant for vaccine design, as it highlights the route of immunization and dose of immunogen must be selected with great care to achieve an optimal effector CD8 1 T-cell response.
